Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 09, 2006. The report serves as a notification of transactions involving directors or persons discharging managerial responsibility, specifically regarding the US Retirement Savings Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific transaction within a retirement plan rather than general corporate financial performance.
Material Changes
A material change occurred in the notional allocation of Ordinary Share ADRs held within the US Retirement Savings Plan ("The Plan"). Following a re-valuation of the cash element of the notional investment, the Administrators notified the registrant of a decrease in the notional allocation on May 05, 2006, at a price of $57.39 per share.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. The transaction was notified in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- The filing reports a decrease in the notional allocation of GSK Ordinary Share ADRs for Mr. R Greig.
- The transaction date was May 05, 2006, with a share price of $57.39.
- The notification was issued on May 09, 2006, by the Plan Administrators.
- This report does not contain financial statements or operational results for the company.